Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Taiwan Biomateiral Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$-0.2 Mil. Taiwan Biomateiral Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-0.2 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Taiwan Biomateiral Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Taiwan Biomateiral Co's Interest Coverage or its related term are showing as below:
ROCO:6649'
s Interest Coverage Range Over the Past 10 Years
Min: 26.17 Med: 54.13 Max: 82.09
Current: 82.09
ROCO:6649's Interest Coverage is ranked better than 74.14% of 464
companies
in the Medical Devices & Instruments industry
Industry Median: 16.08
vs ROCO:6649: 82.09
Taiwan Biomateiral Co (ROCO:6649) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Taiwan Biomateiral Co Interest Coverage Related Terms
Taiwan Biomateiral Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Taiwan Biomateiral Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:6649 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Taiwan Biomateiral Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiwan Biomateiral Co Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Biomateiral Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Taiwan Biomateiral Co's Interest Coverage falls into.
Taiwan Biomateiral Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Taiwan Biomateiral Co did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Taiwan Biomateiral Co (ROCO:6649) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Taiwan Biomateiral Co and its competitors. Over the past decade, Taiwan Biomateiral Co's Interest Coverage has ranged from 26.17 to 82.09. According to the industry distribution chart, Taiwan Biomateiral Co ranks #120 out of 464 companies in the Medical Devices & Instruments industry, placing it in the top 25.9%.
Is Taiwan Biomateiral Co's Interest Coverage too high?
Taiwan Biomateiral Co's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 26.17 to a high of 82.09. Based on the distribution chart, Taiwan Biomateiral Co ranks #120 out of 464 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Taiwan Biomateiral Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Taiwan Biomateiral Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Taiwan Biomateiral Co ranks #120 out of 464 companies for Interest Coverage. This puts Taiwan Biomateiral Co in the upper half of its industry. The industry median Interest Coverage is 16.08. Historically, Taiwan Biomateiral Co's own Interest Coverage has ranged from 26.17 to 82.09 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 464 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Taiwan Biomateiral Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiwan Biomateiral Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Biomateiral Co stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Biomateiral Co (ROCO:6649) is currently considered Possible Value Trap. The stock's GF Value™ is NT$77.96, compared to a current price of NT$37.75 — trading 51.6% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Taiwan Biomateiral Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Taiwan Biomateiral Co (ROCO:6649), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiwan Biomateiral Co (ROCO:6649) Overvalued in 2026?
Based on GuruFocus' analysis, Taiwan Biomateiral Co stock appears to be undervalued.
The current stock price of NT$37.75 is trading 51.6% below its estimated GF Value™ of NT$77.96.
GuruFocus considers Taiwan Biomateiral Co to be Possible Value Trap.
Key valuation signals for ROCO:6649:
Interest Coverage: 0 (At Loss)
GF Value™: NT$77.96 vs. price of NT$37.75 (51.6% below fair value)
No single metric tells the full story. See the ROCO:6649 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiwan Biomateiral Co Ltd is an applied technology Research and Development Institute in Taiwan. It is engaged in the research and development and sales of implantable medical devices. The company's products include Foamagen, stroke interventional treatment devices.
74GF Score
Get the complete analysis for ROCO:6649
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6649 has been successfully added to your 
